Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Fibrin Pad Cardiovascular Study
NCT01681030Phase 2Completed
- Sponsor
- Ethicon
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fibrin Pad in hemorrhage (3 arms), sponsored by Ethicon. Primary endpoint: Hemostasis at the Target Bleeding Site (TBS) at 3 Minutes Following Treatment Application. Started Aug 2012; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01681030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681030.